Ogata, D., Nakano, E., Funakoshi, T., Takahashi, A., Asai, J., Nakamura, M., Namikawa, K., Machida, R., Yokoyama, M., Fukuda, H., Nagasaka, Y., Kurishita, K., Shuda, Y., Anjo, K., Kondo, K., Inaba, M., Kawashima, S., Hitomi, T., Okita, N. T., Yamazaki, N. (2025). The phase II study of pembrolizumab plus lenvatinib for patients with unresectable cutaneous angiosarcoma (Pembro-Lenva for cAS/PLAS trial).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps11586